GT Biopharma, Inc.
GT Biopharma, Inc. (GTBP) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 45 transactions totaling $313.1K, demonstrating a bearish sentiment with -$160.5K in net insider flow. The most recent transaction on Aug 11, 2023 involved a transaction of 200,000 shares valued at $58.0K.
GTBP Insider Activity Summary
Who Is Buying GTBP Stock?
No significant insider buying has been recorded for GTBP in the recent period.
Who Is Selling GTBP Stock?
No significant insider selling has been recorded for GTBP in the recent period.
Is GT Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GTBP is bearish with an Insider Alignment Score of 24/100 and a net flow of -$160.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
GTBP Frequently Asked Questions
Understanding GTBP Insider Activity
Insider trading at GT Biopharma, Inc. (GTBP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading GTBP stock, having executed 45 transactions in the past 90 days. The most active insider is Michael Martin Breen (Executive), who has made 6 transactions totaling $253.3K.
Related Tools
Track GT Biopharma, Inc. Insider Activity
Get notified when executives and directors at GTBP file new Form 4 transactions